Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas

Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas

In recent years, targeted (biological) therapies have become available also for primary cutaneous T-cell lymphomas (PCTCLs) including anti-CD30 (brentuximab vedotin) in mycosis fungoides, primary cutaneous anaplastic large T-cell lymphoma, lymphomatoid papulosis; anti-CCR4 (mogamulizumab) in Sezary...

Full description

Bibliographic Details
Main Authors: Benedetta Sonego, Adalberto Ibatici, Giulia Rivoli, Emanuele Angelucci, Simona Sola, Cesare Massone
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cells
Subjects:
mycosis fungoides
primary cutaneous anaplastic large T-cell lymphoma
lymphomatoid papulosis
brentuximab vedotin
mogamulizumab
tagraxofusp
Online Access:https://www.mdpi.com/2073-4409/12/22/2656

Internet

https://www.mdpi.com/2073-4409/12/22/2656

Similar Items